Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.03
Delayed Data
As of 3:59pm ET
 +0.01 / +0.98%
Today’s Change
0.73
Today|||52-Week Range
1.66
+4.14%
Year-to-Date

Today’s Trading

Previous close1.02
Today’s open1.01
Day’s range1.01 - 1.05
Volume129,673
Average volume (3 months)176,120
Market cap$45.1M
Dividend yield--
Data as of 3:59pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.6
Price/Sales1.47
Price/Book8.56

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...0.000.00%
PTNPalatin Technologies...0.000.00%
HEBHemispherx Biopharma...+0.00+1.96%
IMNPImmune Pharmaceutica...+0.07+3.78%
Data as of 3:59pm ET, 03/30/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account